1. Home
  2. RDVT vs LXRX Comparison

RDVT vs LXRX Comparison

Compare RDVT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Violet Inc.

RDVT

Red Violet Inc.

HOLD

Current Price

$38.98

Market Cap

527.9M

Sector

Technology

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.83

Market Cap

660.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDVT
LXRX
Founded
2017
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.9M
660.9M
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
RDVT
LXRX
Price
$38.98
$1.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$62.00
$4.15
AVG Volume (30 Days)
100.2K
2.2M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
82.00
77.78
EPS
0.91
N/A
Revenue
$90,252,000.00
$49,803,000.00
Revenue This Year
$16.31
N/A
Revenue Next Year
$13.83
N/A
P/E Ratio
$40.54
N/A
Revenue Growth
20.03
60.24
52 Week Low
$33.40
$0.49
52 Week High
$64.14
$1.84

Technical Indicators

Market Signals
Indicator
RDVT
LXRX
Relative Strength Index (RSI) 52.66 63.86
Support Level $35.84 $1.07
Resistance Level $39.63 N/A
Average True Range (ATR) 1.90 0.10
MACD 0.46 0.01
Stochastic Oscillator 89.41 98.57

Price Performance

Historical Comparison
RDVT
LXRX

About RDVT Red Violet Inc.

Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: